[1] |
DALMAU J, TÜZÜN E, WU H Y,et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma[J]. Ann Neurol, 2007, 61(1):25-36. DOI: 10.1002/ana.21050.
|
[2] |
TITULAER M J, MCCRACKEN L, GABILONDO I,et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis:an observational cohort study[J]. Lancet Neurol, 2013, 12(2):157-165. DOI: 10.1016/S1474-4422(12)70310-1.
|
[3] |
LIU Y B, TIAN Y P, GUO R Y,et al. Anti-NMDA receptor encephalitis:retrospective analysis of 15 cases,literature review,and implications for gynecologists[J]. J Healthc Eng, 2022, 2022:4299791. DOI: 10.1155/2022/4299791.
|
[4] |
DING J, ZHOU H H, MA Q R,et al. Expression of NR1 and apoptosis levels in the hippocampal cells of mice treated with MK-801[J]. Mol Med Rep, 2017, 16(6):8359-8364. DOI: 10.3892/mmr.2017.7674.
|
[5] |
NEUPANE C, SHARMA R, PAI Y H,et al. High salt intake recruits tonic activation of NR2D subunit-containing extrasynaptic NMDARs in vasopressin neurons[J]. J Neurosci, 2021, 41(6):1145-1156. DOI: 10.1523/JNEUROSCI.1742-20.2020.
|
[6] |
CRAWLEY O, CONDE-DUSMAN M J, PÉREZ-OTAÑO I. GluN3A NMDA receptor subunits:more enigmatic than ever?[J]. J Physiol, 2022, 600(2):261-276. DOI: 10.1113/JP280879.
|
[7] |
FRANCHINI L, CARRANO N, LUCA M D,et al. Synaptic GluN2A-containing NMDA receptors:from physiology to pathological synaptic plasticity[J]. Int J Mol Sci, 2020, 21(4):1538. DOI: 10.3390/ijms21041538.
|
[8] |
HANSEN K B, YI F, PERSZYK R E,et al. Structure,function,and allosteric modulation of NMDA receptors[J]. J Gen Physiol, 2018, 150(8):1081-1105. DOI: 10.1085/jgp.201812032.
|
[9] |
LIN J F, WANG M J, WANG J R,et al. Ovarian teratoma-related paraneoplastic neurological syndromes[J]. Front Oncol, 2022, 12:892539. DOI: 10.3389/fonc.2022.892539.
|
[10] |
DAY G S, LAIQ S, TANG-WAI D F,et al. Abnormal neurons in teratomas in NMDAR encephalitis[J]. JAMA Neurol, 2014, 71(6):717-724. DOI: 10.1001/jamaneurol.2014.488.
|
[11] |
NOLAN A, BUZA N, MARGETA M,et al. Ovarian teratomas in women with anti-N-methyl-D-aspartate receptor encephalitis:topography and composition of immune cell and neuroglial populations is compatible with an autoimmune mechanism of disease[J]. Am J Surg Pathol, 2019, 43(7):949-964. DOI: 10.1097/PAS.0000000000001249.
|
[12] |
JIANG X Y, LEI S, ZHANG L,et al. Co-expression of NMDA-receptor subunits NR1,NR2A,and NR2B in dysplastic neurons of teratomas in patients with paraneoplastic NMDA-receptor-encephalitis:a retrospective clinico-pathology study of 159 patients[J]. Acta Neuropathol Commun, 2020, 8(1):130. DOI: 10.1186/s40478-020-00999-2.
|
[13] |
CHEFDEVILLE A, TREILLEUX I, MAYEUR M E,et al. Immunopathological characterization of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitis[J]. Acta Neuropathol Commun, 2019, 7(1):38. DOI: 10.1186/s40478-019-0693-7.
|
[14] |
MAKUCH M, WILSON R, AL-DIWANI A,et al. N-methyl-D-aspartate receptor antibody production from germinal center reactions:therapeutic implications[J]. Ann Neurol, 2018, 83(3):553-561. DOI: 10.1002/ana.25173.
|
[15] |
HAMMER C, STEPNIAK B, SCHNEIDER A,et al. Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity[J]. Mol Psychiatry, 2014, 19(10):1143-1149. DOI: 10.1038/mp.2013.110.
|
[16] |
WANG R, GUAN H Z, REN H T,et al. CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis[J]. Seizure, 2015, 29:137-142. DOI: 10.1016/j.seizure.2015.04.005.
|
[17] |
YU Y C, WU Y, CAO X L,et al. The clinical features and prognosis of anti-NMDAR encephalitis depends on blood brain barrier integrity[J]. Mult Scler Relat Disord, 2021, 47:102604. DOI: 10.1016/j.msard.2020.102604.
|
[18] |
DALMAU J, ARMANGUÉ T, PLANAGUMÀ J,et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists:mechanisms and models[J]. Lancet Neurol, 2019, 18(11):1045-1057. DOI: 10.1016/S1474-4422(19)30244-3.
|
[19] |
CLARK R M, LYNCH M P, KOLP R,et al. The N-methyl-D-aspartate receptor,a precursor to N-methyl-D-aspartate receptor encephalitis,is found in the squamous tissue of ovarian teratomas[J]. Int J Gynecol Pathol, 2014, 33(6):598-606. DOI: 10.1097/PGP.0000000000000104.
|
[20] |
XIAO Y Y, LI J, LIU L J,et al. Clinicopathological characteristics of dysplastic teratomous neuroglia with anti-N-methyl-D-aspartate receptor encephalitis[J]. Clin Immunol, 2020, 210:108271. DOI: 10.1016/j.clim.2019.108271.
|
[21] |
JIANG H Y, YE H X, WANG Y F,et al. Anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma in south china-clinical features,treatment,immunopathology,and surgical outcomes of 21 cases[J]. Dis Markers, 2021, 2021:9990382. DOI: 10.1155/2021/9990382.
|
[22] |
ZHAO X Y, LI J, ZHU Q,et al. HLA-A and HLA-DRB1 may play a unique role in ovarian teratoma-associated anti-N-methyl-D-aspartate receptor encephalitis[J]. Reprod Biol Endocrinol, 2020, 18(1):107. DOI: 10.1186/s12958-020-00661-5.
|
[23] |
李善姬,狄文,王登凤,等. 卵巢畸胎瘤相关抗N-甲基-D-天冬氨酸受体脑炎的临床诊治中国专家共识(2022年版)[J]. 中国实用妇科与产科杂志, 2022, 38(9):900-906. DOI: 10.19538/j.fk2022090109.
|
[24] |
GRAUS F, TITULAER M J, BALU R,et al. A clinical approach to diagnosis of autoimmune encephalitis[J]. Lancet Neurol, 2016, 15(4):391-404. DOI: 10.1016/S1474-4422(15)00401-9.
|
[25] |
CHOI W K, LEE D H, CHO D H,et al. Primary malignant melanoma arising from ruptured ovarian mature cystic teratoma with elevated serum CA 19-9:a case report and review of literature[J]. BMC Womens Health, 2019, 19(1):149. DOI: 10.1186/s12905-019-0853-8.
|
[26] |
MAŁGORZATA S Ż, ANNA K G, RESZEĆ J,et al. Growing teratoma syndrome and gliomatosis peritonei in a 15-year-old girl with immature ovarian teratoma:case report and review of the literature[J]. J Pediatr Adolesc Gynecol, 2021, 34(6):885-889. DOI: 10.1016/j.jpag.2021.07.009.
|
[27] |
RAO S, SMITH D A, GULER E,et al. Past,present,and future of serum tumor markers in management of ovarian cancer:a guide for the radiologist[J]. Radiographics, 2021, 41(6):1839-1856. DOI: 10.1148/rg.2021210005.
|
[28] |
DAI Y, ZHANG J J, REN H T,et al. Surgical outcomes in patients with anti-N-methyl D-aspartate receptor encephalitis with ovarian teratoma[J]. Am J Obstet Gynecol, 2019, 221(5):485.e1-485.e10. DOI: 10.1016/j.ajog.2019.05.026.
|
[29] |
MASGHATI S, NOSRATIAN M, DORIGO O. Anti-N-methyl-aspartate receptor encephalitis in identical twin sisters:role for oophorectomy[J]. Obstet Gynecol, 2014, 123(2 Pt 2 Suppl 2):433-435. DOI: 10.1097/AOG.0000000000000078.
|
[30] |
HUANG Q Y, XIE Y, HU Z P,et al. Anti-N-methyl-D-aspartate receptor encephalitis:a review of pathogenic mechanisms,treatment,prognosis[J]. Brain Res, 2020, 1727:146549. DOI: 10.1016/j.brainres.2019.146549.
|
[31] |
GU J X, CHEN Q, GU H D,et al. Research progress in teratoma-associated anti-N-methyl-D-aspartate receptor encephalitis:the gynecological perspective[J]. J Obstet Gynaecol Res, 2021, 47(11):3749-3757. DOI: 10.1111/jog.14984.
|
[32] |
WU C Y, WU J D, CHEN C C. The association of ovarian teratoma and anti-N-methyl-D-aspartate receptor encephalitis:an updated integrative review[J]. Int J Mol Sci, 2021, 22(20):10911. DOI: 10.3390/ijms222010911.
|
[33] |
NGUYEN L, WANG C. Anti-NMDA receptor autoimmune encephalitis:diagnosis and management strategies[J]. Int J Gen Med, 2023, 16:7-21. DOI: 10.2147/IJGM.S397429.
|
[34] |
SEERY N, BUTZKUEVEN H, O'BRIEN T J,et al. Contemporary advances in anti-NMDAR antibody (ab)-mediated encephalitis[J]. Autoimmun Rev, 2022, 21(4):103057. DOI: 10.1016/j.autrev.2022.103057.
|
[35] |
XU X L, LU Q, HUANG Y,et al. Anti-NMDAR encephalitis:a single-center,longitudinal study in China[J]. Neurol Neuroimmunol Neuroinflamm, 2020, 7(1):e633. DOI: 10.1212/NXI.0000000000000633.
|
[36] |
CHO E H, BYUN J M, PARK H Y,et al. The first case of Anti-N-methyl-D-aspartate receptor encephalitis (Anti-NMDAR encephalitis) associated with ovarian mucinous cystadenoma:a case report[J]. Taiwan J Obstet Gynecol, 2019, 58(4):557-559. DOI: 10.1016/j.tjog.2019.05.022.
|
[37] |
FRUNZA-STEFAN S, WHITLATCH H B, RAO G G,et al. Unusual case of anti-N-methyl-D-aspartic acid-receptor(NMDA-R) encephalitis and autoimmune polyglandular syndrome(APS)[J]. BMJ Case Rep, 2018, 2018:bcr2018224821. DOI: 10.1136/bcr-2018-224821.
|